Physician profile
Hemindermeet Singh
NPI 1821345695
$8,824.46
in general payments reported to CMS, 2019-2025
40 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $686 · 2021: $1,387 · 2022: $3,355 · 2023: $1,562 · 2024: $930 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,406.43 | 2019-2025 | Optis |
| Medtronic, INC. | $1,387.93 | 2021-2025 | Onyx Frontier, Launcher, Euphora |
| Esperion Therapeutics, INC. | $589.38 | 2020-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $504.60 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.82 | 2021-2023 | Jardiance |
| Inari Medical, INC. | $399.13 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $379.55 | 2020-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $376.05 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $361.53 | 2021-2023 | Verquvo |
| Shockwave Medical, INC | $347.48 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $279.50 | 2020-2025 | Lifevest |
| Atricure, INC. | $273.18 | 2021-2024 | |
| Abiomed | $243.00 | 2021-2024 | Impella |
| Amgen INC. | $226.42 | 2019-2023 | Repatha |
| Pfizer INC. | $218.19 | 2019-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $189.25 | 2023 | Assure Wcd |
| Amarin Pharma, INC. | $180.33 | 2020-2022 | |
| Cardiovascular Systems INC. | $159.40 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $150.85 | 2024 | Optimizer |
| Penumbra, INC. | $141.54 | 2024 | Indigo System |
| Astellas Pharma US INC | $113.92 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $78.86 | 2021-2023 | Arcalyst |
| Collegium Pharmaceutical, INC. | $68.77 | 2021-2023 | Belbuca |
| Sanofi-Aventis U.S. LLC | $43.59 | 2019-2022 | |
| Lundbeck LLC | $33.98 | 2019-2023 | Vyepti |
| Lexicon Pharmaceuticals, INC. | $32.54 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $29.30 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $28.30 | 2023 | Opsumit, Uptravi |
| Medtronic Vascular, INC. | $27.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.39 | 2019-2022 | |
| Bioventus LLC | $19.88 | 2022 | |
| Biodelivery Sciences International, INC. | $16.77 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.39 | 2022 | |
| Alfasigma USA, INC. | $14.05 | 2021 | |
| Philips North America LLC | $13.87 | 2023 | |
| Amryt Pharma Holdings LTD | $13.11 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemindermeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.